Oral Semaglutide 25 mg Matches Injectable 2.4 mg for Weight Loss Efficacy in Adults with Obesity
Semaglutide 25 mg Oral Versus Semaglutide 2.4 mg Injectable: An Indirect Treatment Comparison of Weight Loss Outcomes.
Abstract
Oral semaglutide 25 mg and injectable semaglutide 2.4 mg demonstrate comparable weight loss efficacy and safety profiles in adults with obesity, an indirect comparison confirms.
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.
